Vitamin d3 analogues and pathway to mediate disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/59 (2006.01) A61K 31/575 (2006.01)

Patent

CA 2179288

Methods for controlling genomic and nongenomic cellular responses which are mediated by 1.alpha.,25-(OH)2 vitamin D3[1.alpha.,25-(OH)2D3]. The method involves treating cells which exhibit nongenomic responses to 1.alpha.,25- (OH)2D3 with the vitamin C3 analogues 1,25(OH)2-previtamin D3 or 1.beta.,25- (OH)2 vitamin D3 [1.beta.,25-(OH)2D3]. The 1,25(OH)2-previtamin D3 functions as an agonist to promote the cellular response while the 1.beta.,25-(OH)2D3 functions as an antagonist. Transcaltachia is one of the nongenomic responses which is affected and can be controlled by administration of 1,25(OH)2- previtamin D3 or 1.beta.,25-(OH)2D3. Fifteen additional analogues are disclosed which may be used to control genomic and/or nongenomic cellular responses.

Procédés de régulation de réponses cellulaires génomiques et non génomiques induites par 1.alpha.,25-(OH)¿2? vitamine D¿3?[1.alpha.,25-(OH)¿2?D¿3?]. Le procédé consiste à traiter des cellules présentant des réponses non génomiques à 1.alpha.,25-(OH)¿2?D¿3? à l'aide des analogues de vitamine D¿3? 1,25(OH)¿2?-provitamine D¿3? ou 1.beta.,25-(OH)¿2? vitamine D¿3? [1.beta.,25-OH)¿2?D¿3?]. La 1,25(OH)¿2?-provitamine D¿3? fait office d'agoniste stimulant la réponse cellulaire tandis que la 1.beta.,25-(OH)¿2?D¿3? fait office d'antagoniste. La transcaltachia est une des réponses non génomique affectée et pouvant être régulée par administration de 1,25(OH)¿2?-provitamine D¿3? ou 1.beta.,25-(OH)¿2?D¿3?. L'invention concerne également quinze autres analogues que l'on peut utiliser pour réguler des réponses cellulaires génomiques et/ou non génomiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vitamin d3 analogues and pathway to mediate disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vitamin d3 analogues and pathway to mediate disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin d3 analogues and pathway to mediate disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1947616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.